Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | — |
| Procurement Method: | Call-off from a framework agreement |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £90,000 |
| Release Date: | 6 March 2023 |
| Application Deadline: | 10 February 2023 |
| Contract Start Date: | 13 February 2023 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £90,000 |
| Award decision date: | 24 February 2023 |
| Award status: | Active |
Identifying the best approach for the NHS in relation to absorbing the cost impact of the initial recommendations stemming from the NICE MTA undertaken for Type 1 Diabetes hybrid closed-loop medical technology
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
10 February 2023
Closed
Estimated Value
£90,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 31 March 2023 |
| Contract Duration: | 2 months |
| Procurement ID (OCID): | ocds-b5fd17-486e2b9d-d727-47d2-8ea8-f06e58a22351 |
| Notice Reference: | 78545f00-3e63-43ac-b55f-f87807003f41-621599 |